← Back to Search

Meningioma Group for Meningioma

N/A
Recruiting
Led By Daniel Prevedello, MD
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Summary

The purpose of this prospectively enrolling trial is to assess long-term cognitive outcomes of patients undergoing surgery for resection of a meningioma associated with the frontal and temporal lobes.

Eligible Conditions
  • Meningioma
  • Skull Base Meningioma
  • Frontal Meningioma
  • Temporal Meningioma
  • Cognitive Impairment
  • Cognitive Decline
  • Cognitive Dysfunction

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Overall cognitive function
Secondary outcome measures
Cognitive function based on surgical approach using Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
Cognitive function based on tumor location using Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
Other outcome measures
Surgical comorbidities based on quality of life questionnaire PROMIS-29

Trial Design

1Treatment groups
Experimental Treatment
Group I: Meningioma GroupExperimental Treatment1 Intervention
This group will include all patients in the study, regardless of location (frontal or temporal lobe) or surgical approach (endoscopic endonasal or craniotomy). Fifty patients will be included in the cohort

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
859 Previous Clinical Trials
642,715 Total Patients Enrolled
2 Trials studying Meningioma
407 Patients Enrolled for Meningioma
Daniel Prevedello, MDPrincipal Investigator - Ohio State University Wexner Medical Center
Ohio State University Hospital - Wexner Medical Center, Richard M. Ross Heart Hospital
2 Previous Clinical Trials
28 Total Patients Enrolled
~2 spots leftby Dec 2024